e - ISBN : 978-93-6252-833-9Publisher: Iterative International Publishers (IIP), Selfypage Developers Pvt Ltd.Volume: 3-2024
AIM & SCOPE
This book series invites all the Specialists, Professors, Doctors, Scientists, Academicians, Healthcare professionals, Nurses, Students, Researchers, Business Delegates, and Industrialists across the globe to publish their insights and convey recent developments in the field of Nursing, Pharmaceutical Research and Innovations in Pharma Industry. Book series on Pharmacy and Nursing covers research work in a set of clinical sciences and medicine.The content of the book is as follows.
Chapter 1CHEMICAL STABILITY OF DRUGShttps://www.doi.org/10.58532/V3BAPN3CH1 Chapter 2PHARMACOKINETICShttps://www.doi.org/10.58532/V3BAPN3CH2 Chapter 3DOSAGE FORM DESIGNhttps://www.doi.org/10.58532/V3BAPN3CH3 Chapter 4RADIOCHEMISTRYhttps://www.doi.org/10.58532/V3BAPN3CH4 Chapter 5IMPLEMENTATION OF GREEN TECHNOLOGY & GREEN CHEMISTRY IN PHARMACEUTICAL INDUSTRY: A NEWER APPROACH FOR SUSTAINABILITY IN PHARMACEUTICAL INDUSTRY https://www.doi.org/10.58532/V3BAPN3CH5 Chapter 6PHYTO-PHOSPHOLIPID COMPLEXES AND ITS APPLICATION IN CANCER THERAPYhttps://www.doi.org/10.58532/V3BAPN3CH6 Chapter 7RECENT DEVELOPMENTS IN THE MUCOADHESIVE DRUG DELIVERY SYSTEM DOMAINhttps://www.doi.org/10.58532/V3BAPN3CH7 Chapter 8NATURAL PRODUCTS AS INSPIRATION FOR NOVEL ANTIBIOTICS: CHEMICAL DIVERSITY AND MECHANISM OF ACTIONhttps://www.doi.org/10.58532/V3BAPN3CH8 Chapter 9RECENT ADVANCEMENTS IN THE NOVEL DRUG DELIVERY DRUG CARRIER SYSTEMS FOR THE MANAGEMENT OF CARDIOVASCULAR DISEASES (CVDs)https://www.doi.org/10.58532/V3BAPN3CH9 Chapter 10PRODRUG BASED NANOPARTICLE THERAPEUTICS: CHALLENGES AND FUTURE PROSPECTShttps://www.doi.org/10.58532/V3BAPN3CH10 Chapter 11FUTURE DIRECTIONS IN UTILIZING POLYMERIC NANOFORMULATIONS FOR PLANT BIOACTIVES AND EXTRACTShttps://www.doi.org/10.58532/V3BAPN3CH11
Chapter 12CURRENT ADVANCES IN THE TREATMENT OF PARKINSON’S DISEASE BASED ON NANOTECH-NOLOGYhttps://www.doi.org/10.58532/V3BAPN3CH12 Chapter 13ETHOSOMES FOR DRUG DELIVERY OF NATURAL PRODUCTS IN DIABETEShttps://www.doi.org/10.58532/V3BAPN3CH13 Chapter 14NANOTECHNOLOGY BASED APPROACHES FOR ENHANCING BIOAVAILABILITY OF POORLY SOLUBLE DRUGShttps://www.doi.org/10.58532/V3BAPN3CH14 Chapter 15A NEW WEAPON FOR NEW POLLUTANTS: NANO-BIOREMEDIATIONhttps://www.doi.org/10.58532/V3BAPN3CH15 Chapter 16CURRENT TRAJECTORY AND PROSPECTIVE POTENTIAL OF PHARMACOGENOMICS IN PERSONALIZED MEDICINES https://www.doi.org/10.58532/V3BAPN3CH16 Chapter 17BIOPHARMACEUTICS: MULTIPLE DOSAGE REGIMENhttps://www.doi.org/10.58532/V3BAPN3CH17 Chapter 18NANO-DRUG DELIVERY SYSTEMS FOR THE ENHANCEMENT OF BIOAVAILABILITY AND BIOACTIVITYhttps://www.doi.org/10.58532/V3BAPN3CH18 Chapter 19RECENT TRENDS IN THE EMERGENCE OF INVASOMES FOR TRANSDERMAL DELIVERY OF DRUGShttps://www.doi.org/10.58532/V3BAPN3CH19 Chapter 20SYNERGISTIC ANTIMICROBIAL EMULGEL FORMULATION OF QUERCETIN DIHYDRATE AND ZINC OXIDE: A POTENTIAL APPROACH FOR AZOLE-RESISTANT CANDIDIASIS TREATMENThttps://www.doi.org/10.58532/V3BAPN3CH20
EDITORIAL BOARD MEMBERS
Dr Ravikant Gupta Associate Professor Oriental University Indore, India.
Dr. Nilutpal Sharma Bora Associate Professor Department of PharmacognosyNETES Institute of Pharmaceutical ScienceNEMCARE Group of InstitutionsKamrup, Assam, India.
Sunil Kumar Founder and Managing Director Department of Medicinal ChemistrySGT UniversityGurugram, Haryana, India.
R. Prabhu Assistant professor College of PharmacyMadurai Medical CollegeMadurai, Tamil Nadu, India.